Skip to main content

News Archive

News Archive - Nicole Mlynaryk

New Look at an Ancient Disease: Study Finds Novel Treatment Targets for Gout

December 13, 2022

UC San Diego scientists identify a new molecular model and potential therapeutic target for gout, the most common form of inflammatory arthritis.

Enzyme Drives Cognitive Decline in Mice, Provides New Target for Alzheimer’s

November 28, 2022

UC San Diego researchers identify the PKCα enzyme as a promising therapeutic target in Alzheimer’s disease; a mutation that increases its activity led to biochemical, cellular and cognitive impairments in mice.

UC San Diego Sanford Stem Cell Institute Launches Stem Cells Into Space

November 22, 2022

The UC San Diego Sanford Stem Cell Institute leads its first space launch, sending stem cells into space aboard the International Space Station. The NASA-partnered study will take advantage of the microgravity environment of space to study accelerated aging in stem cells.

UC San Diego Awarded $8M to Expand Stem Cell Therapy Clinical Trials

November 21, 2022

UC San Diego Alpha Stem Cell Clinic awarded $8M to expand clinical trials of novel stem cell therapies. The CIRM award will advance partnerships between academic and industry experts in San Diego to expedite clinical trials for patients with difficult-to-treat diseases.

Brain Organoids Reveal in Detail the Harms of Prenatal Alcohol Exposure

November 18, 2022

UC San Diego researchers used human brain organoids to study the effects of prenatal alcohol exposure on neural development, revealing significant harms in molecular detail.

Genetic Score Predicts Risk of Lethal Prostate Cancer

October 31, 2022

Researchers at UC San Diego report that a polygenic hazard score based on 290 genetic variants could be an effective tool for predicting genetic risk of lethal prostate cancer, which kills more than 34,000 men in the U.S. annually.

Treated or Not, COVID-19 Recurrence Seems Symptomatic for Some

October 31, 2022

UC San Diego researchers and others report that more than one-third of the COVID-19 patients who did not receive any treatment experienced complete resolution of symptoms for at least two consecutive days, but then subsequently reported a return of symptoms.

UC San Diego Joins National Trial to Test Drug for Treating MPOX

October 27, 2022

UC San Diego will be one of multiple sites assessing the safety and efficacy of tecovirimat as a potential treatment for human monkeypox. Marketed as TPOXX, tecovirimat is an antiviral currently approved for treatment of human smallpox in adults and children caused by the variola virus.

‘Leaky’ Activity of Mutated Enzyme Underlies Neurodegenerative Disease

October 3, 2022

UC San Diego study finds enhanced PKCγ activity drives spinocerebellar ataxia type 14; suggests inhibiting the enzyme may have therapeutic potential

First-Ever Mycobiome Atlas Describes Associations between Cancers and Fungi

September 29, 2022

An international team of scientists, co-led by researchers at the University of California San Diego School of Medicine, has created the first pan-cancer mycobiome atlas—a survey of 35 types of cancer and their associated fungi.
Category navigation with Social links